Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PMD

Psychemedics (PMD) Stock Price, News & Analysis

Psychemedics logo

About Psychemedics Stock (NASDAQ:PMD)

Advanced Chart

Key Stats

Today's Range
$2.46
$2.77
50-Day Range
$2.32
$3.21
52-Week Range
$1.50
$3.25
Volume
113,627 shs
Average Volume
36,377 shs
Market Capitalization
$16.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Psychemedics and its competitors with MarketBeat's FREE daily newsletter.

PMD Stock News Headlines

Psychemedics Releases 2025 Workforce Insights Report
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.
Psychemedics announces reverse stock split, forward stock split
Psychemedics reminds stockholders to cast votes for Annual Meeting
See More Headlines

PMD Stock Analysis - Frequently Asked Questions

Psychemedics Corporation (NASDAQ:PMD) posted its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.09) EPS for the quarter. The business had revenue of $5.20 million for the quarter. Psychemedics had a negative trailing twelve-month return on equity of 32.32% and a negative net margin of 9.26%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Psychemedics investors own include Pfizer (PFE), NVIDIA (NVDA), DraftKings (DKNG), UnitedHealth Group (UNH), Canopy Growth (CGC), Advanced Micro Devices (AMD) and McDonald's (MCD).

Company Calendar

Last Earnings
11/12/2024
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Healthcare
Current Symbol
NASDAQ:PMD
CIK
806517
Employees
140
Year Founded
1985

Profitability

EPS (Trailing Twelve Months)
($0.51)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.86 million
Net Margins
-9.26%
Pretax Margin
-9.73%
Return on Equity
-32.32%
Return on Assets
-18.53%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
1.82
Quick Ratio
1.82

Sales & Book Value

Annual Sales
$19.68 million
Price / Sales
0.83
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.84 per share
Price / Book
3.18

Miscellaneous

Outstanding Shares
6,110,000
Free Float
5,256,000
Market Cap
$16.31 million
Optionable
Not Optionable
Beta
N/A

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:PMD) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners